Ailioaie Oana, Essig Marie, Levassort Hélène
Service de néphrologie, Université Paris-Saclay, Site Ambroise-Paré, AP-HP, Boulogne-Billancourt, France.
Service de néphrologie, Université Paris-Saclay, Site Ambroise-Paré, AP-HP, Boulogne-Billancourt, France; Inserm UMRS 1018, Équipe épidémiologie clinique, Université Paris-Saclay, UVSQ, CESP, Villejuif, France.
Soins Gerontol. 2024 Mar-Apr;29(166):8-13. doi: 10.1016/j.sger.2024.01.003. Epub 2024 Feb 14.
Chronic kidney disease (CKD) affects almost 10% of the world's population, and over 30% of people aged over 70 [1,2]. The overall incidence of treated CKD is stable in France, but continues to rise sharply in people aged over 85 [3]. In its advanced stages, CKD is associated with numerous complications linked to disturbances in water, acid-base and phosphocalcium balance, as well as anemia and increased cardiovascular risk. A better understanding of risk factors, improved practices to promote nephroprotection, and progress in therapeutic education and preparation for suppletive techniques would help reduce this risk.
慢性肾脏病(CKD)影响着全球近10%的人口,在70岁以上人群中的患病率超过30%[1,2]。在法国,接受治疗的CKD总体发病率保持稳定,但在85岁以上人群中仍在急剧上升[3]。在其晚期,CKD与许多并发症相关,这些并发症与水、酸碱和钙磷平衡紊乱以及贫血和心血管风险增加有关。更好地了解风险因素、改进促进肾脏保护的措施以及在治疗教育和替代技术准备方面取得进展,将有助于降低这种风险。